tiprankstipranks
VOO ETF News, 1/15/2025
PremiumMarket NewsVOO ETF News, 1/15/2025
3d ago
Regeneron CEO: We have 40 drugs in development
Premium
The Fly
Regeneron CEO: We have 40 drugs in development
3d ago
QQQ ETF News, 1/14/2025
Premium
Market News
QQQ ETF News, 1/14/2025
4d ago
Regeneron reports ‘positive’ results from Phase 3 C-POST trial
PremiumThe FlyRegeneron reports ‘positive’ results from Phase 3 C-POST trial
5d ago
Regeneron announces strategic collaboration with Truveta
Premium
The Fly
Regeneron announces strategic collaboration with Truveta
5d ago
Regeneron price target lowered to $950 from $1,000 at Oppenheimer
Premium
The Fly
Regeneron price target lowered to $950 from $1,000 at Oppenheimer
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100